Skip to main content
Signal8

abrdn Life Sciences Investors (HQL)

abrdn Life Sciences Investors logo

abrdn Life Sciences Investors

NYSE:HQL
-0.76%$17.49
Mkt Cap$531.71M
EV-
Float30.41M
O/S30.41M
VOL57K sh
$ Vol$1M
RVOL0.49×
Inst Own26.8%
SI0.6%
Net Cash/Sh-
Div Yield12.81%
Dilution
abrdn Life Sciences Investors logoNYSE:HQL$17.49-0.76%
Historical Data
DateOpenHighLowCloseVolume
Nov 18, 202617.5117.7417.4817.4957,156
Nov 17, 202617.7517.7717.2817.62138,690
Nov 16, 202618.5119.0917.7617.81296,927
Nov 13, 202618.3418.4917.8818.28107,218
Nov 12, 202618.8118.8118.2318.3491,731
Nov 11, 202618.7718.9518.6018.9577,996
Nov 10, 202618.5918.7918.2418.67100,257
Nov 9, 202618.2118.7017.9718.66136,358
Nov 6, 202617.3618.1117.3618.09102,728
Nov 5, 202618.3618.3617.3017.36157,085
Nov 4, 202618.5618.5617.9018.36123,120
Nov 3, 202617.8518.2917.8518.12130,095
Nov 2, 202618.4219.0017.8917.9879,334
Oct 30, 202618.7718.7718.2518.4486,549
Oct 29, 202618.5318.8218.4018.74102,863
Oct 28, 202618.0718.3117.9918.2892,974
Oct 27, 202617.6718.0017.6618.00166,843
Oct 26, 202617.8517.8917.6017.7070,693
Oct 23, 202617.9917.9917.5117.7360,790
Oct 22, 202617.9118.1017.8117.95118,565
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
InsiderTypeShares
Mahai Chris LaVictoire profile photoMahai Chris LaVictoirePurchase527
Pittard Christian profile photoPittard ChristianPurchase7.9K
Saba Capital Management, L.P. profile photoSaba Capital Management, L.P.Sale41.6K
Saba Capital Management, L.P. profile photoSaba Capital Management, L.P.Sale7.0K
Saba Capital Management, L.P. profile photoSaba Capital Management, L.P.Sale40.2K
Saba Capital Management, L.P. profile photoSaba Capital Management, L.P.Sale24.3K
Shareholders
26.8%
Institutional
(86)
0.0%
Insiderⓘ
(2)
0.0%
5%+ Owners
(0)
73.2%
Unattributed (incl. retail)ⓘ
Institutional26.8%
Insider0.0%
Unattributed (incl. retail)73.2%
Top Shareholders
NameShares%
First Trust Portfolios L.P. logo
First Trust Portfolios L.P.
· also on 13F· joint filing· may incl. warrants· filed Oct 2026
3.6M11.7%
MORGAN STANLEY logo
MORGAN STANLEY
2.1M6.8%
Penserra Capital Management LLC logo
Penserra Capital Management LLC
838.9K2.8%
RAYMOND JAMES FINANCIAL INC logo
RAYMOND JAMES FINANCIAL INC
740.1K2.4%
LPL Financial LLC logo
LPL Financial LLC
552.8K1.8%
NEEDHAM INVESTMENT MANAGEMENT LLC logo
NEEDHAM INVESTMENT MANAGEMENT LLC
443.0K1.5%
FLAGSHIP HARBOR ADVISORS, LLC logo
FLAGSHIP HARBOR ADVISORS, LLC
417.4K1.4%
Allspring Global Investments Holdings, LLC logo
Allspring Global Investments Holdings, LLC
416.0K1.4%
Advisors Asset Management, Inc. logo
Advisors Asset Management, Inc.
208.9K0.7%
AMERIPRISE FINANCIAL INC logo
AMERIPRISE FINANCIAL INC
168.6K0.6%
Sources: 13F, Form 4, 13D/13GO/S: 30.4M · date not recorded · SEC EDGAR
Insiders & Institutional Holders
About

Tekla Life Sciences Investors, a closed-ended equity mutual fund, is expertly managed by Tekla Capital Management LLC. This U.S.-domiciled fund, which commenced operations on February 20, 1992, and was formerly known as H&Q Life Sciences Investors, seeks investment opportunities in publicly traded companies worldwide.

Its primary focus lies within the broad life sciences sector, encompassing a diverse range of industries such as biotechnology, pharmaceuticals, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, and medical devices and supplies. The fund also extends its investment purview to include the agriculture and environmental management sectors.

It predominantly allocates capital to growth-oriented businesses, particularly those with small market capitalizations. Investment decisions are rooted in rigorous fundamental analysis, which assesses critical factors like a company's market position for its offerings, the acumen of its management team, its technological prowess, and its capability to either self-finance expansion or attract external funding to build its portfolio. The fund's performance is gauged against two key benchmarks: the NASDAQ Biotech Index and the S&P 500 Index.

Key Metrics
Market Cap$531.71M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership26.82%

based on 30.41M shares outstanding

Sector--
Industry--
ExchangeNYSE
CountryUSUS
IPO DateMay 1, 1992
Shares Outstanding30.41M
Authorized Shares
Float30.41M
52-Week Range
$15.66$22.67
$17.49(26th percentile)
Volume
Average Daily Volume113.37K
57.16K today vs 113.37K avg(-50%)

30d Avg

113.37K

60d Avg

120.38K

90d Avg

124.45K

Earnings
Dividend History
TTM Yield
12.81%
Paid quarterly
Annual (LTM)
$2.24
Latest
$1.5000
Nov 20, 26
5Y Growth
+11.67%
per year
Compliance Status
Loading compliance data...

abrdn Life Sciences Investors (NYSE: HQL) traded at $17.49 on Nov 18, 2026, down 0.76% from the previous close of $17.62. 52-week range: $15.66 to $22.67.